YLL053C is an open reading frame located in the S. cerevisiae genome, also known by the alternative designation L0587 . The protein encoded by this gene has been assigned the UniProt identifier P0CD98 and is officially described as a "Putative uncharacterized protein YLL053C" . This classification indicates that while the protein's existence has been confirmed, its biological function remains largely unknown or has not been experimentally verified.
The full-length YLL053C protein consists of 152 amino acids with the following sequence:
MWFPQIIAGMAAGGAASAMTPGKVLFTNALGLGCSRSRGLFLEMFGTAVLCLTVLMTAVEKRETNFMAALPIGISLFMAHMALTGYTGTGVNPARSLGAAVAARYFPHYHWIYWISPLLGAFLAWSVWQLLQILDYTTYVNAEKAAGQKKED
This primary structure information represents a fundamental starting point for any investigation into the protein's function. Analysis of this sequence could potentially reveal motifs, domains, or structural elements that might offer clues about its biological role, though such detailed analyses are not provided in the available resources.
For research purposes, recombinant YLL053C has been successfully expressed in Escherichia coli expression systems. Specifically, the full-length protein (amino acids 1-152) has been produced with an N-terminal histidine tag to facilitate purification . This approach represents a standard methodology for producing sufficient quantities of the protein for biochemical and structural studies.
The recombinant YLL053C protein is typically supplied as a lyophilized powder with a purity greater than 90% as determined by SDS-PAGE analysis . This high level of purity is crucial for subsequent functional and structural studies to ensure that observed effects can be attributed specifically to YLL053C rather than contaminants.
Despite being identified and sequenced, the biological function of YLL053C remains largely unknown. The paucity of information about this protein highlights a significant gap in our understanding of the S. cerevisiae proteome. While many yeast proteins have been extensively characterized through various high-throughput and targeted studies, YLL053C appears to be among those that have received limited research attention.
While direct information about YLL053C is limited, insights might be gained by examining neighboring or related ORFs. For instance, another uncharacterized ORF, YLL056C, which is located in proximity to YLL053C in the yeast genome, has been characterized as an NADH-dependent aldehyde reductase belonging to the short-chain dehydrogenase/reductase (SDR) family . This finding demonstrates that previously uncharacterized ORFs in this genomic region can encode proteins with specific enzymatic activities.
YLL056C was found to be upregulated under conditions of high furfural or 5-(hydroxymethyl)-2-furaldehyde concentrations, with its transcription likely controlled by transcription factors Yap1p, Hsf1p, Pdr1/3p, Yrr1p, and Stb5p . Such contextual information might provide clues about potential regulatory mechanisms or stress-response roles for proteins encoded by ORFs in this region, including YLL053C.
The availability of recombinant YLL053C opens numerous avenues for research into its biochemical properties and biological function. Given its uncharacterized status, the recombinant protein could be utilized in:
Protein-protein interaction studies to identify binding partners
Structural analyses through crystallography or NMR spectroscopy
Enzymatic activity screens against various substrates
Localization studies using tagged versions of the protein
Expression pattern analyses under various stress conditions
Comparative genomics approaches could yield valuable insights into YLL053C function. By examining homologs or orthologs in other yeast species or fungi, researchers might uncover conserved domains or patterns that suggest functional roles. This approach has proven successful for other previously uncharacterized yeast proteins.
While specific information about YLL053C's regulation is scarce, understanding the broader context of transcriptional regulation in S. cerevisiae provides valuable perspective. Studies on other yeast genes have shown that 14-3-3 proteins play significant roles in regulating transcription factors such as Rtg3 . These regulatory networks control various cellular processes, including gluconeogenesis, ergosterol biosynthesis, and stress response .
Given that multiple uncharacterized ORFs in S. cerevisiae have been found to be regulated under specific stress conditions or metabolic states, it is plausible that YLL053C might also be subject to condition-specific regulation. Transcriptomic analyses under various environmental stresses or metabolic conditions could potentially reveal conditions under which YLL053C is significantly up- or down-regulated, providing clues about its function.
Computational approaches could provide preliminary insights into YLL053C function. Sequence analysis using tools for motif recognition, secondary structure prediction, or homology modeling might reveal structural features that suggest potential functions. Additionally, comparisons with proteins of known function might identify distant homologs that could inform hypotheses about YLL053C's role.
Integration of available high-throughput data, such as protein-protein interaction networks, gene expression profiles, and fitness data from genome-wide deletion studies, could place YLL053C within a functional context. Such analyses might reveal associations with specific cellular processes or stress responses, guiding more targeted experimental investigations.
KEGG: sce:YLL053C
STRING: 4932.YLL053C
YLL053C is a putative uncharacterized protein from Saccharomyces cerevisiae (strain ATCC 204508 / S288c), commonly known as baker's yeast. In the Saccharomyces Genome Database (SGD), it is cataloged under the systematic name YLL053C, with an alternative ORF name of L0587. The protein is currently classified as "putative uncharacterized," indicating limited functional annotation in major databases . The gene is documented in SGD, which provides comprehensive integrated biological information for S. cerevisiae, including genomic context and sequence data derived from the reference genome of laboratory strain S288C .
The full amino acid sequence of YLL053C consists of 152 amino acids:
MWFPQIIAGMAAGGAASAMTPGKVLFTNALGLGCSRSRGLFLEMFGTAVLCLTVLMTAVEKRETNFMAALPIGISLFMAHMALTGYTGTGVNPARSLGAAVAARYFPHYHWIYWISPLLGAFLAWSVWQLLQILDYTTYVNAEKAAGQKKED
The protein has a Uniprot accession number of P0CD98, and its expression region spans positions 1-152, representing the full-length protein . Based on its amino acid composition, the protein appears to contain hydrophobic regions that are characteristic of membrane-associated proteins, which aligns with its potential role in transport functions as suggested by some research findings .
For optimal stability, recombinant YLL053C protein should be stored at -20°C, with extended storage preferably at -80°C. The protein is typically supplied in a Tris-based buffer containing 50% glycerol, specifically optimized for this protein's stability . Researchers should avoid repeated freezing and thawing cycles, as this can compromise protein integrity. For ongoing experiments, working aliquots may be stored at 4°C for up to one week, but no longer, to prevent degradation . When handling the protein, standard precautions for recombinant proteins should be observed, including the use of sterile technique and appropriate personal protective equipment.
CRISPR-Cas9 mediated transporter disruption has been demonstrated as an efficient method for characterizing transporters like YLL053C. Recent research has established protocols for generating transporter disruption libraries in yeast to study their influence on metabolite levels . To implement this approach for YLL053C specifically:
Design guide RNAs targeting the YLL053C open reading frame
Transform the CRISPR-Cas9 construct into the appropriate S. cerevisiae strain
Verify disruption through sequencing or PCR-based genotyping
Assess phenotypic changes using relevant biosensor systems
When conducting disruption experiments, it is essential to include appropriate controls and to consider the potential for off-target effects. Studies have shown that YLL053C disruption can significantly impact metabolite yields, with different effects observed for different compounds, suggesting a role in metabolite transport or regulation .
Biosensor systems utilizing transcription factors coupled with fluorescent reporters have proven effective for studying transporter function in S. cerevisiae. For investigating YLL053C specifically, researchers have successfully employed:
Transcription factor-based biosensors (e.g., PcaQ-based systems for PCA detection)
Fluorescent reporter systems (typically GFP) under the control of metabolite-responsive elements
These biosensors should be implemented in the appropriate strain background, with optimization of media conditions being crucial for reliable results. It's important to note that biosensor responses are dependent on intracellular metabolite concentrations, which may correlate differently with extracellular concentrations depending on the transporter's nature . Therefore, validation of biosensor data with direct metabolite measurements is strongly recommended.
Media selection significantly impacts biosensor performance - researchers have observed that mineral medium (MM) at pH 4.5 or pH 6.0 provides better results than YPD or synthetic defined media when using certain biosensors such as the PcaQ system for PCA detection .
When designing experiments to investigate YLL053C function, researchers should adhere to rigorous experimental design principles as outlined in guidelines for preclinical pharmacological research:
Include appropriate controls (positive, negative, and vehicle controls where applicable)
Ensure adequate sample sizes based on power calculations
Implement randomization and blinding where possible
Control for batch effects and environmental variables
Furthermore, when reporting results related to YLL053C studies, authors should provide essential information required for reproducibility, including detailed methodological descriptions, statistical analyses performed, and complete data presentation . This approach is particularly important for studies involving putative uncharacterized proteins like YLL053C, where functional characterization is still evolving.
Experimental evidence indicates that YLL053C disruption has significant but varying effects on different metabolic pathways. Studies have shown that:
This differential impact suggests that YLL053C may play a complex role in metabolite transport or regulation, potentially affecting multiple pathways differently. The mechanism behind these effects remains to be fully elucidated, but could involve direct transport activity, influence on membrane integrity, or indirect effects on cellular metabolism and homeostasis .
Comparative analyses place YLL053C among transporters that show similar functional patterns in disruption studies. Based on metabolite production phenotypes, transporters can be categorized into distinct functional groups:
| Group | Effect on CCM Yield | Effect on PCA Yield | Examples |
|---|---|---|---|
| I | Increased | Decreased | YLL053C, SDH4, MEP1, YPQ2 |
| II | Increased | Increased | AVT7, TPO2 |
| III | Increased | Unchanged | GET3, MEP2, YKL050C |
YLL053C belongs to Group I, wherein disruption results in increased CCM yield but decreased PCA yield . This classification provides valuable information for researchers interested in metabolic engineering and transporter function. Interestingly, combination studies involving multiple transporter disruptions, including YLL053C, failed to provide additive improvements in CCM production compared to single disruptions, suggesting potential compensatory mechanisms or broader metabolic perturbations .
To determine the subcellular localization of YLL053C, researchers can employ several complementary approaches:
Fluorescent protein tagging:
C-terminal or N-terminal fusion with GFP or other fluorescent proteins
Visualization using confocal microscopy
Consideration of potential interference with protein function
Subcellular fractionation followed by Western blotting:
Careful separation of membrane fractions (plasma membrane, vacuolar membrane, mitochondrial membrane)
Use of specific antibodies against YLL053C or epitope tags
Comparison with known compartment markers
Immunogold electron microscopy:
Ultra-structural localization at high resolution
Requires specific antibodies against YLL053C
When interpreting localization data, it's important to consider that YLL053C's amino acid sequence (MWFPQIIAGMAAGGAASAMTPGKVLFTNALGLGCSRSRGLFLEMFGTAVLCLTVLMTAVEKRETNFMAALPIGISLFMAHMALTGYTGTGVNPARSLGAAVAARYFPHYHWIYWISPLLGAFLAWSVWQLLQILDYTTYVNAEKAAGQKKED) contains hydrophobic regions consistent with membrane localization , supporting its putative role as a transporter.
Transcriptome analysis represents a powerful approach to elucidate YLL053C function by examining global gene expression changes in response to its disruption or overexpression. Researchers can implement this strategy by:
Performing RNA-Seq or microarray analysis comparing wild-type and YLL053C-disrupted strains
Analyzing data under varying conditions (e.g., different carbon sources or stress conditions)
Identifying co-regulated genes that may function in similar pathways
Previous transcriptome studies in respiratory S. cerevisiae strains have demonstrated the value of this approach for identifying functional relationships between genes and metabolic pathways . When analyzing transcriptome data, researchers should be aware of potential opposite-direction changes that may occur between different datasets, as observed in some respiratory yeast studies where certain genes showed contradictory expression patterns across different experimental conditions .
When encountering contradictory results regarding YLL053C function, researchers should consider implementing the following methodological approaches:
Strain-specific effects investigation:
Compare phenotypes across multiple strain backgrounds
Document genetic differences between strains used in different studies
Conditional functionality assessment:
Test function under various media compositions
Examine effects under different growth phases and stress conditions
Multi-omics integration:
Combine transcriptomics, proteomics, and metabolomics data
Use systems biology approaches to model complex interactions
Complementation studies:
Reintroduce wild-type or mutated versions of YLL053C to disruption strains
Assess rescue of phenotypes to confirm direct causality
These approaches can help resolve apparent contradictions, such as the differential effects of YLL053C disruption on different metabolites (increased CCM yield versus decreased PCA yield) , by providing a more complete understanding of the protein's context-dependent functions.
Although direct evidence for YLL053C involvement in stress response is limited, its potential role can be investigated through:
Expression profiling under various stress conditions:
Oxidative stress
Osmotic stress
Nutrient limitation
Temperature shifts
Phenotypic analysis of YLL053C-disrupted strains under stress:
Growth rate comparisons
Viability assessments
Metabolite production changes
Interaction studies with known stress response proteins:
Co-immunoprecipitation
Yeast two-hybrid analysis
Genetic interaction mapping
Transporter-mediated stress responses often involve regulation of ion homeostasis, nutrient acquisition, or export of toxic compounds. The differential effects of YLL053C disruption on metabolite production suggest it could play a role in cellular homeostasis under specific conditions, potentially contributing to stress adaptation mechanisms.
To identify the specific substrates of YLL053C, researchers should consider implementing the following approaches:
Direct transport assays:
Expression in heterologous systems (e.g., Xenopus oocytes)
Radiolabeled or fluorescently labeled substrate uptake measurements
Competition assays with potential substrates
Metabolomics profiling:
Comparative metabolomics of wild-type and YLL053C-disrupted strains
Targeted analysis of key metabolite classes
Flux analysis using isotope-labeled precursors
Structural prediction and docking:
Homology modeling based on related transporters
In silico docking of potential substrates
Validation of predictions through site-directed mutagenesis
These approaches, particularly when used in combination, can provide complementary evidence for substrate specificity. The existing data showing YLL053C disruption affects both CCM and PCA levels provides initial clues about metabolic pathways that may be directly or indirectly influenced by this putative transporter.
CRISPR-Cas9 technology offers sophisticated approaches for YLL053C functional studies beyond straightforward gene disruption:
Base editing for introducing specific mutations:
Create point mutations without double-strand breaks
Generate allelic series to probe structure-function relationships
Modify potential regulatory regions
CRISPRi/CRISPRa for modulating expression:
Implement CRISPR interference to reduce expression
Use CRISPR activation to increase expression
Create conditional expression systems
Domain-specific tagging:
Precise insertion of epitope or fluorescent tags
Minimal disruption of protein function
Targeting specific domains for functional analysis
When implementing these advanced CRISPR approaches, researchers should carefully design guide RNAs to minimize off-target effects and validate editing efficiency using appropriate sequencing methods. The efficiency of CRISPR-Cas9 for transporter disruption has been demonstrated in yeast studies , suggesting these more sophisticated applications would be technically feasible for YLL053C functional characterization.